Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage
- 1 September 2014
- journal article
- Published by Elsevier in Annals of Epidemiology
- Vol. 24 (9) , 666-672.e2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer PatientsMedical Care, 2016
- Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary CohortsMedical Care, 2014
- Identifying Specific Chemotherapeutic Agents in Medicare DataMedical Care, 2013
- Identification of metastatic cancer in claims dataPharmacoepidemiology and Drug Safety, 2012
- Differences in Late‐Stage Diagnosis, Treatment, and Colorectal Cancer‐Related Death Between Rural and Urban African Americans and Whites in GeorgiaThe Journal of Rural Health, 2011
- Ten-Year Survival and Cost Following Breast Cancer Recurrence: Estimates from SEER-Medicare DataValue in Health, 2008
- A Refined Comorbidity Measurement Algorithm for Claims-Based Studies of Breast, Prostate, Colorectal, and Lung Cancer PatientsAnnals of Epidemiology, 2007
- Identification in Administrative Databases of Women Dying of Breast CancerJournal of Clinical Oncology, 2006
- Use of ICD‐9 coding as a proxy for stage of disease in lung cancerPharmacoepidemiology and Drug Safety, 2002
- The Utility of Medicare Claims Data for Measuring Cancer StageMedical Care, 1999